norethindrone and Neoplasms, Cystic, Mucinous, and Serous

norethindrone has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koskela-Niska, V; Lyytinen, H; Pukkala, E; Riska, A; Ylikorkala, O1

Other Studies

1 other study(ies) available for norethindrone and Neoplasms, Cystic, Mucinous, and Serous

ArticleYear
Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
    Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Confidence Intervals; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Postmenopause; Progestins; Risk Assessment; Time Factors

2013